T-cell depletion

T-cell depletion is a medical procedure that involves the removal of T cells from a sample of blood. This process is often used in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GVHD).

Overview

T-cell depletion is a method used to reduce the risk of GVHD, a serious and potentially life-threatening condition that can occur after an allogeneic HSCT. GVHD occurs when the donated bone marrow or peripheral blood stem cells view the recipient's body as foreign and attack the body. By depleting T cells from the graft, the risk of GVHD can be significantly reduced.

Procedure

T-cell depletion is performed ex vivo (outside the body). The graft is treated with antibodies that bind to T cells, and these cells are then removed. The T-cell-depleted graft is then returned to the patient's body.

Risks and Complications

While T-cell depletion can reduce the risk of GVHD, it can also increase the risk of graft failure, infection, and relapse of the original disease. This is because T cells play a crucial role in the immune response, including fighting infections and killing cancer cells.

Research

Research is ongoing to improve the methods of T-cell depletion and to balance the benefits and risks. This includes the development of methods to selectively deplete certain subsets of T cells (such as those that are likely to cause GVHD) while sparing others.

See also

• Hematopoietic stem cell transplantation
• Graft-versus-host disease
• T cell